If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Immunoglobulins Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Plasmacytoma Medicine & Life Sciences
Immunoglobulin Genes Medicine & Life Sciences
Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2020

Proteasome Inhibitors
Multiple Myeloma
Drug Resistance
Multiple Myeloma
Transgenic Mice
Pharmaceutical Preparations
Transgenic Mice
Therapeutics
Preclinical Drug Evaluations
Libraries
Skin
Liver
Population

Research Output 1978 2019

Discovering genetic interactions bridging pathways in genome-wide association studies

Fang, G., Wang, W., Paunic, V., Heydari, H., Costanzo, M., Liu, X., Liu, X., VanderSluis, B., Oately, B., Steinbach, M. S., Van Ness, B. G., Schadt, E. E., Pankratz, N. D., Boone, C., Kumar, V. & Myers, C. L., Dec 1 2019, In : Nature communications. 10, 1, 4274.

Research output: Contribution to journalArticle

Open Access
genome
Genome-Wide Association Study
Genes
Breast Neoplasms
interactions
Open Access
Incidental Findings
Exome
Epilepsy
Mutation
Genotype
5 Citations (Scopus)

Molecular signatures of multiple myeloma progression through single cell RNA-Seq

Jang, J. S., Li, Y., Mitra, A. K., Bi, L., Abyzov, A., van Wijnen, A. J., Baughn, L., Van Ness, B. G., Rajkumar, V., Kumar, S. & Jen, J., Jan 1 2019, In : Blood cancer journal. 9, 1, 2.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
RNA
Genes
Oxidative Phosphorylation
Plasma Cells
3 Citations (Scopus)

The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies

Harding, T., Baughn, L., Kumar, S. & Van Ness, B. G., Apr 1 2019, In : Leukemia. 33, 4, p. 863-883 21 p.

Research output: Contribution to journalReview article

Precision Medicine
Multiple Myeloma
Drug Resistance
Technology
Biomarkers
7 Citations (Scopus)

EZH2 inhibitors sensitize myeloma cell lines to panobinostat resulting in unique combinatorial transcriptomic changes

Harding, T., Swanson, J. & Van Ness, B., Apr 24 2018, In : Oncotarget. 9, 31, p. 21930-21942 13 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Cell Line
Histone Deacetylase Inhibitors
Epigenomics
Recurrence